BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3258530)

  • 1. Complement is not activated in ABO-haemolytic disease of the newborn.
    Brouwers HA; Overbeeke MA; Huiskes E; Bos MJ; Ouwehand WH; Engelfriet CP
    Br J Haematol; 1988 Mar; 68(3):363-6. PubMed ID: 3258530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct antiglobulin reaction in ABO-haemolytic disease of the newborn.
    Romano EL; Hughes-Jones NC; Mollison PL
    Br Med J; 1973 Mar; 1(5852):524-6. PubMed ID: 4540300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the best predictor of the severity of ABO-haemolytic disease of the newborn?
    Brouwers HA; Overbeeke MA; van Ertbruggen I; Schaasberg W; Alsbach GP; van der Heiden C; van Leeuwen EF; Stoop JW; Engelfriet CP
    Lancet; 1988 Sep; 2(8612):641-4. PubMed ID: 2901516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal antibodies against fetal blood group antigens A or B: lytic activity of IgG subclasses in monocyte-driven cytotoxicity and correlation with ABO haemolytic disease of the newborn.
    Brouwers HA; Overbeeke MA; Ouwehand WH; Keuning K; van Ertbruggen I; van Leeuwen EF; Stoop JW; Engelfriet CP
    Br J Haematol; 1988 Dec; 70(4):465-9. PubMed ID: 3219297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complement-activating capacity of maternal IgG antibodies to blood group A in paired mother/child serum samples.
    Hari Y; von Allmen EC; Boss GM; Naiem A; Gittermann M; Nydegger UE
    Vox Sang; 1998; 74(2):95-100. PubMed ID: 9501407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive cord blood "DAT" due to anti-Le(a): absence of hemolytic disease of the newborn.
    Abhyankar S; Silfen S; Rao SP; Vinciguerra C; Dimiaio TM
    Am J Pediatr Hematol Oncol; 1989; 11(2):184-5. PubMed ID: 2787608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG subclasses of anti-A and anti-B antibodies bound to the cord red cells in ABO incompatible pregnancies.
    Ukita M; Takahashi A; Nunotani T; Kihana T; Watanabe S; Yamada N
    Vox Sang; 1989; 56(3):181-6. PubMed ID: 2728395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
    Wu Y; Wu Y; Yang Y; Chen B; Li J; Guo G; Xiong F
    Front Immunol; 2021; 12():698541. PubMed ID: 35003054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of the severity of ABO haemolytic disease of the newborn by cord blood tests.
    Whyte J; Graham H
    Acta Paediatr Scand; 1981 Mar; 70(2):217-22. PubMed ID: 7195139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
    Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
    Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of the Coombs test in ABO incompatibility].
    Bel Comos J; Ribera Crusafont A; Natal Pujol A; Coroleu Lletget W; Pujol Posch N; Prats Viñas J
    An Esp Pediatr; 1991 Oct; 35(4):248-50. PubMed ID: 1763851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence, laboratory diagnosis and serologic prediction of hemolytic disease of newborn infants due to ABO incompatibility].
    Schönitzer D; Frisch H
    Padiatr Padol; 1984; 19(3):263-78. PubMed ID: 6472867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An explanation of the failure of the direct antiglobulin test to detect erythrocyte sensitization in ABO haemolytic disease of the newborn and observations on pinocytosis of IgG anti-A antibodies by infant (cord) red cells.
    Voak D; Williams MA
    Br J Haematol; 1971 Jan; 20(1):9-23. PubMed ID: 5099693
    [No Abstract]   [Full Text] [Related]  

  • 14. How to use: the direct antiglobulin test in newborns.
    Keir A; Agpalo M; Lieberman L; Callum J
    Arch Dis Child Educ Pract Ed; 2015 Aug; 100(4):198-203. PubMed ID: 25395493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement is not activated in AB0-haemolytic disease of the newborn: two exceptions.
    Pujol M; Ribera A; Abella E; Natal A; Bel J; Coroleu W
    Vox Sang; 1991; 61(1):76. PubMed ID: 1949716
    [No Abstract]   [Full Text] [Related]  

  • 16. Monogamous bivalency of IgG antibodies. I. Deficiency of branched ABHI-active oligosaccharide chains on red cells of infants causes the weak antiglobulin reactions in hemolytic disease of the newborn due to ABO incompatibility.
    Romans DG; Tilley CA; Dorrington KJ
    J Immunol; 1980 Jun; 124(6):2807-11. PubMed ID: 7189535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A detailed serological study on the prediction and diagnosis of ABO haemolytic disease of the newborn (ABO HD).
    Voak D; Bowley CC
    Vox Sang; 1969 Nov; 17(5):321-48. PubMed ID: 5308005
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of complement binding by anti-D and anti-M antibodies employing labelled antiglobulin antibodies.
    Freedman J; Massey A; Chaplin H; Monroe MC
    Br J Haematol; 1980 Jun; 45(2):309-18. PubMed ID: 6776980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of newborn direct antiglobulin testing practice in United States and Canadian transfusion services.
    Crowe EP; Goel R; Andrews J; Meyer EK; Wong TE; Sloan SR; Delaney M; Lieberman L; Cushing MM
    Transfusion; 2021 Apr; 61(4):1080-1092. PubMed ID: 33629748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.